Publications

09 Nov 2010
First Look

First Look: November 9, 2010

brands" and a "branded house." Purchase this case:http://cb.hbsp.harvard.edu/cb/product/511039-PDF-ENG Note on International Trade Finance C. Fritz Foley, Matthew Johnson, and David LaneHarvard Business School Note 211-007... View Details

Keywords: Sean Silverthorne

06 Mar 2012
First Look

First Look: March 6

learning, can reorient research about the link between identity-group-based diversity and performance. How to Make Finance Work Authors:Robin Greenwood and David S. Scharfstein Publication:Harvard Business Review 90, no. 3 (March 2012)... View Details

Keywords: Sean Silverthorne

07 Aug 2007
First Look

First Look: August 7, 2007

providing information for students on CWA's history, the nature of Section 363 auctions, and the bidders who were involved in the process. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=908004 Connectivity in View Details

Keywords: Martha Lagace

05 Aug 2014
First Look

First Look: August 5

important and previously unidentified metric for assessing the health of the human emotional ecosystem. Publisher's link: http://www.hbs.edu/faculty/Publication%20Files/quoidbach%20et%20al_372259e1-d8a0-4488-b09a-b4978f06f406.pdf August... View Details

Keywords: Sean Silverthorne

19 Mar 2013
First Look

First Look: March 19

PublicationsSetting Health Priorities: Strategy versus Tactics Authors:Chu, Michael, David E. Bloom, and Elizabeth Cafiero Publication:Impact: The Magazine of PSI Abstract Health decision makers throughout... View Details

Keywords: Sean Silverthorne

August 2012 (Revised August 2024)
Case

ABC Pharmaceuticals

By: Regina E. Herzlinger and Erik R. Sparks

This case asks students to price a new drug that is in Stage II of its clinical trials. It contains detailed estimates of the time required and costs for all the steps needed to commercialize a drug in the U.S. Students will learn virtually all the steps required to... View Details

Keywords: Drug Development; Price; Product; Product Launch; Health Industry; Health Industry; Health Industry

Article

Time-Driven Activity-Based Costing in Emergency Medicine

By: Robert S. Kaplan, Brian J. Yun, Anand M. Prabhakar, Jonathan Warsh, John Brennan, Kyle E. Dempsey and Ali S. Raja

Value in emergency medicine is determined by both patient-important outcomes and the costs associated with achieving them. However, measuring true costs is challenging. Without an understanding of costs, emergency department (ED) leaders will be unable to determine... View Details

Keywords: Time-Driven Activity-Based Costing; Emergency Room; Health Care and Treatment; Value; Cost Management; Activity Based Costing and Management

Read Now

January 2021 (Revised June 2021)
Case

Hester Pharmaceuticals (A): A Pricing Dilemma

By: Dante Roscini and John Masko

In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details

Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy

September 2024
Case

Cathay Cargo: Turnaround Short Haul, or Double Crew Long Haul?

By: Willy Shih and Billy Chan

Tom Owen, Director Cargo at Cathay Pacific Airways, had a problem. During the Covid-19 pandemic, the grounding of passenger flights meant the sudden loss of 50% of the airline's cargo carrying capacity. But the bigger challenge was that the Hong Kong government imposed... View Details

Keywords: Operations; Resource Allocation; Cash Flow; Governing Rules, Regulations, and Reforms; Health Pandemics; Organizational Change and Adaptation; Decision Choices and Conditions; Air Transportation Industry; Hong Kong

December 2004 (Revised April 2006)
Case

Nestle and Alcon--The Value of a Listing

By: Mihir A. Desai, Vincent Dessain and Anders Sjoman

In response to a perceived undervaluation by the capital markets, Nestle is considering divesting a part of its ophthalmology subsidiary, Alcon, and must decide on a listing location. In the process, students are challenged to wrestle with the valuation of a... View Details

Keywords: Business Conglomerates; International Finance; Corporate Entrepreneurship; Markets; Taxation; Business Subsidiaries; Valuation; Health Industry; Health Industry; Europe; United States

March 2017
Case

Cantel Medical

By: John R. Wells and Gabriel Ellsworth

Cantel Medical Corporation provided infection prevention and control products and services for patients, caregivers, and other healthcare providers. In 2016, Cantel generated sales of $665 million and net profits of $60 million, double the levels of five years earlier.... View Details